A Bitter Pill for Novo, Green Backlash Hits Orsted, Schneider Electric Down

On this episode of Stock Movers:
- Novo Nordisk slumped after a pill from rival Eli Lilly helped patients shed weight and control blood sugar about as well as its injected blockbuster Ozempic. The stock dropped as much as 9.8% to 380 kroner early in Copenhagen, the first trading day since the Thursday announcement that buoyed Lilly.
- The Trump administration halted work on an offshore wind farm being built off New York amid a broader review of the sector’s projects. The halt is the latest — and perhaps biggest — blow to a sector that seemed on the verge of major growth just four years ago.
- European electrification stocks are trading lower and underperforming the broader market on Tuesday after an analyst at Wells Fargo Securities said Amazon.com’s web services business is pausing some data center leases. Kevin Miller, vice president of global data centers at Amazon Web Services, said in a post on LinkedIn there “haven’t been any recent fundamental changes in our expansion plans,” though there has been “routine capacity management,” which can be based on such factors as price and location

See omnystudio.com/listener for privacy information.